Search Results

There are 14018 results for: content related to: Rare and serious cardiac side effects during ropinirole titration

  1. You have free access to this content
    Ropinirole, a Non-Ergoline Dopamine Agonist

    CNS Drug Reviews

    Volume 11, Issue 3, September 2005, Pages: 253–272, Wolfgang H. Jost and Dieter Angersbach

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2005.tb00046.x

  2. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  3. PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

    Movement Disorders

    Volume 26, Issue 7, June 2011, Pages: 1259–1265, Fabrizio Stocchi, Luigi Giorgi, Brian Hunter and Anthony HV Schapira

    Version of Record online : 5 APR 2011, DOI: 10.1002/mds.23498

  4. Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson’s disease

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 571–577, N. Hattori, K. Hasegawa and T. Sakamoto

    Version of Record online : 6 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01336.x

  5. You have free access to this content
    Comparison of ropinirole controlled- and immediate-release in Japanese patients with advanced Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 3, Issue 1, January 2015, Pages: 18–24, Nobutaka Hattori, Hiroshi Nishioka, Kazuko Hasegawa and on behalf of the SWAN Study Investigators

    Version of Record online : 25 NOV 2014, DOI: 10.1111/ncn3.128

  6. DA agonists - Non-Ergot derivaties: Ropinirole

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S98–S102,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5570

  7. Ropinirole for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine HO Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001516

  8. Lack of a Pharmacokinetic Interaction at Steady State Between Ropinirole and L-Dopa in Patients with Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 2, February 1999, Pages: 150–156, Dr. Anne C. Taylor, Dr. Almisbah Beerahee, Dr. David R. Citerone, Dr. Matthew J. Cyronak, Dr. Terry J. Leigh, Dr. Katherine L. Fitzpatrick, Dr. Arturo Lopez-Gil, Dr. Sarosh D. Vakil, Dr. Eileen Burns and Dr. Graham Lennox

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.19.3.150.30927

  9. D-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats

    British Journal of Pharmacology

    Volume 174, Issue 18, September 2017, Pages: 3058–3071, David Lindenbach, Banibrata Das, Melissa M Conti, Samantha M Meadows, Aloke K Dutta and Christopher Bishop

    Version of Record online : 11 AUG 2017, DOI: 10.1111/bph.13937

  10. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study

    Movement Disorders

    Volume 13, Issue 1, January 1998, Pages: 46–51, Prof. Amos D. Korczyn, David J. Brooks, Ehrout R. Brunt, Warner H. Poewe, Olivier Rascol and Fabrizzio Stocchi

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870130112

  11. Linear Pharmacokinetic Behavior of Ropinirole during Multiple Dosing in Patients with Parkinson's Disease

    The Journal of Clinical Pharmacology

    Volume 40, Issue 6, June 2000, Pages: 641–646, Dr. Jean Hubble, William C. Koller, Dr. Paul Atchison, Mrs. Anne C. Taylor, Mr. David R. Citerone, Mr. Barry D. Zussman, Dr. Carl J. Friedman and Mr. Noele Hawker

    Version of Record online : 11 DEC 2013, DOI: 10.1002/j.1552-4604.2000.tb05990.x

  12. You have free access to this content
    Interactions between domperidone and ropinirole, a novel dopamine D2- receptor agonist.

    British Journal of Clinical Pharmacology

    Volume 32, Issue 4, October 1991, Pages: 483–488, C de Mey, D Enterling, I Meineke and S Yeulet

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1991.tb03935.x

  13. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine HO Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001517

  14. A single and multiple dose study to investigate the pharmacokinetics of a prolonged release formulation of ropinirole in healthy Chinese subjects

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 2, March/April 2014, Pages: 84–92, Hongzhong Liu, Ji Jiang, Hongyun Wang, Xia Chen, Tao Liu, Haijun Cao, Jonathan Palmer, Anita Gu and Pei Hu

    Version of Record online : 30 OCT 2013, DOI: 10.1002/cpdd.28

  15. Development and Validation of Ropinirole Hydrochloride and its Related Compounds by UPLC in API and Pharmaceutical Dosage Forms

    Journal of the Chinese Chemical Society

    Volume 57, Issue 3A, June 2010, Pages: 348–355, CH Krishnaiah, M. Vishnu Murthy, A. Raghupathi Reddy, Ramesh Kumar and K. Mukkanti

    Version of Record online : 25 SEP 2013, DOI: 10.1002/jccs.201000052

  16. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom Disease): Results from a prospective, multicenter study over 66 weeks

    Movement Disorders

    Volume 27, Issue 2, February 2012, Pages: 277–283, Diego García-Borreguero, Birgit Högl, Luigi Ferini-Strambi, John Winkelman, Christina Hill-Zabala, Afsaneh Asgharian and Richard Allen

    Version of Record online : 4 JAN 2012, DOI: 10.1002/mds.24889

  17. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 631–641, Eleni C. Maratos, Michael J. Jackson, Ronald K. B. Pearce and Peter Jenner

    Version of Record online : 11 JUL 2001, DOI: 10.1002/mds.1149

  18. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease

    Movement Disorders

    Volume 24, Issue 14, 30 October 2009, Pages: 2121–2127, Kelly E. Lyons and Rajesh Pahwa

    Version of Record online : 18 SEP 2009, DOI: 10.1002/mds.22750

  19. Effect of Ropinirole on Sleep Outcomes in Patients with Restless Legs Syndrome: Meta-Analysis of Pooled Individual Patient Data from Randomized Controlled Trials

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 3, March 2009, Pages: 255–262, Dr. Richard A. Hansen, Dr. Liping Song, Dr. Charity G. Moore, Dr. Alicia W. Gilsenan, Dr. Mimi M. Kim, Dr. Michael O. Calloway and Dr. Michael D. Murray

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.3.255

  20. You have free access to this content
    D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways

    FEBS Letters

    Volume 582, Issue 5, March 05, 2008, Pages: 603–610, Sheng Chen, Xiaojie Zhang, Dehua Yang, Yunlan Du, Liang Li, Xuping Li, Ming Ming and Weidong Le

    Version of Record online : 31 JAN 2008, DOI: 10.1016/j.febslet.2008.01.028